The content on this site is intended for healthcare professionals only
Pembrolizumab for head and neck cancer
Pembrolizumab shows promising activity against head and neck cancer
ecancermedicalscience editor's choice for March 2015
ecancermedicalscience editor's choice for February 2015
The role of health economics in cancer outcomes research
Biobanking biological materials and linkage to clinical information
2nd EurocanPlatform translational research course is good for networking
Reasons to attend the EurocanPlatform translational research course 2015
Immunotherapy of cancer: recent progress and future challenges
Epigenome deregulation in cancer
Aims and successes of the 2nd EurocanPlatform project translational research course
New approaches and new partnership models for biomarker based clinical research
